CSRXP POLL: AMERICAN VOTERS OVERWHELMINGLY AGREE BIG PHARMA SHOULD SUSPEND PRICE HIKES DURING PANDEMIC

Survey Finds 83 Percent of Americans Believe Drug Companies Should Stop Price Increases, Majority More Concerned About Rx Prices as a Result of COVID-19 For Immediate Release Contact: Jon Conradi

06-30-2020 Read More

ICYMI: Big Pharma Must Suspend Summer Price Hikes Amid Historic Economic Uncertainty

Big Pharma Must Suspend Summer Price Hikes Amid Historic Economic Uncertainty By Lauren Aronson Morning Consult June 23, 2020 Before the COVID-19 crisis, more than 58 million Americans struggled

06-23-2020 Read More

CSRXP: GALLUP SURVEY FINDS NINE IN TEN AMERICANS WORRIED ABOUT RISING PRESCRIPTION DRUG PRICES

New Poll Underscores Need for Big Pharma to Suspend Summer Price Hikes and for Policymakers to Advance Market-Based Rx Pricing Solutions For Immediate Release Contact: Jon Conradi 860-235-3884

06-18-2020 Read More

CSRxP: Court Ruling Underscores Need For Congressional Action To Boost Prescription Drug Transparency

Lawmakers Must Step-in to Enact DTC List Price Disclosures, Additional Measures to Shine a Light on Big Pharma’s Pricing Practices For Immediate Release Contact: Jon Conradi 860-235-3884

06-17-2020 Read More

CSRxP Launches “No Price Hikes” Campaign Urging Big Pharma To Suspend Summer Price Hikes

Drug Companies Must Forgo Mid-Year Price Increases While Millions of Americans Grapple With Historic Economic Uncertainty For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected]

06-2-2020 Read More

CSRXP: PUBLIC-PRIVATE PARTNERSHIP WILL HELP DELIVER RELIEF FROM BIG PHARMA’S INSULIN PRICE-GOUGING

Coalition Applauds Positive Step from the Administration to Lower Insulin Prices, Encourages Additional Action to Hold Drug Companies Accountable For Immediate Release Contact: Jon Conradi

05-27-2020 Read More

BIG PHARMA EARNINGS WATCH: AMGEN, ABBVIE & BRISTOL-MYERS SQUIBB

Brand Name Drug Companies Complete Sweep of Big Pharma Giants Who Beat Wall Street Expectations After Price Hikes In January In a final round of first quarter earnings reports, three more Big Pharma

05-7-2020 Read More

DOSE OF REALITY: BIG PHARMA NEGLECTED ANTIVIRAL, VACCINE RESEARCH IN RUN-UP TO COVID-19 CRISIS

Drug Companies’ Focus on Most Profitable Treatments Hampers Pandemic Readiness Big Pharma neglected antiviral and vaccine research and development (R&D) for years in the run-up to the COVID-19

04-30-2020 Read More

BIG PHARMA EARNINGS WATCH: ASTRAZENECA & GLAXOSMITHKLINE

Brand Name Drug Companies See Surging Profits After Hiking Prices Today, brand name drug giants AstraZeneca and GlaxoSmithKline (GSK) announced rising profits for the first quarter of 2020 –

04-29-2020 Read More

Sign-up for updates

  • This field is for validation purposes and should be left unchanged.